| David Campbell, Ph.D. | President and Chief Executive Officer | FY2025 | |
| Byron Robinson, Ph.D., J.D. | Former Chief Strategy Officer | FY2025 | |
| Janeen Doyle | Chief Corporate and Business Development Officer | FY2025 | |
| Zachariah McIver, D.O., Ph.D. | Former Chief Medical Officer | FY2025 | |
| Thomas DiRaimondo, Ph.D. | Chief Scientific Officer | FY2025 |
5 executives
Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.